Skip to main content

Michael Kelly

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael Kelly

Michael Kelly is recorded as Board Member at Neogenomics Inc (NEO). Neogenomics Inc reported in an 8-K filed October 5, 2026 that Michael Kelly was appointed Lead Independent Director, effective January 4, 2027.

“the Board appointed Michael Kelly, a current independent Board member, as Lead Independent Director, effective as of January 4, 2027.”
Neogenomics Inc Form 8-K, filed October 5, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Neogenomics Inc

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.